Click here to close
Hello! We notice that you are using Internet Explorer, which is not supported by Xenbase and may cause the site to display incorrectly.
We suggest using a current version of Chrome,
FireFox, or Safari.
Cancer Sci
2010 Apr 01;1014:862-8. doi: 10.1111/j.1349-7006.2009.01473.x.
Show Gene links
Show Anatomy links
Antitumor and anti-angiogenesis immunity induced by CR-SEREX-identified Xenopus RHAMM.
Yang HS
,
Zhang DM
,
Deng HX
,
Peng F
,
Wei YQ
.
???displayArticle.abstract???
Immunization with xenogeneic antigens is an attractive approach to induce cross-reactive humoral and cellular immunity to inhibit tumor growth or angiogenesis. To identify novel xenogenic targets for immunotherapy, we have developed a modified serological expression cloning (SEREX) strategy, termed Cross-reactive SEREX (CR-SEREX). Among 78 positive clones identified by CR-SEREX, Xenopus receptor for hyaluronic-acid-mediated motility (xRHAMM) was most frequently identified (18 times), indicating the strongest immunogenic potential for xenogenic immunotherapy. A DNA vaccine based on xRHAMM effectively induced a protective antitumor immunity against local tumor and lung metastasis in B16 melanoma mouse models. Angiogenesis was inhibited and cell apoptosis was increased within tumors. Antitumor activity of xRHAMM worked through stimulation of an antigen-specific cellular response as well as through a specific humoral response against RHAMM, as confirmed by the depletion of immune cell subsets in vivo. Thus, a xenogenic vaccine based on xRHAMM induced an effective immunity against B16 melanoma cells and endothelial cells.
Bergman,
Long-term survival of dogs with advanced malignant melanoma after DNA vaccination with xenogeneic human tyrosinase: a phase I trial.
2003, Pubmed
Bergman,
Long-term survival of dogs with advanced malignant melanoma after DNA vaccination with xenogeneic human tyrosinase: a phase I trial.
2003,
Pubmed
Ciesielski,
Antitumor effects of a xenogeneic survivin bone marrow derived dendritic cell vaccine against murine GL261 gliomas.
2006,
Pubmed
Crowe,
Relationships between stem cells and cancer stem cells.
2004,
Pubmed
Fukui,
Anti-tumor activity of dendritic cells transfected with mRNA for receptor for hyaluronan-mediated motility is mediated by CD4+ T cells.
2006,
Pubmed
Gallo,
Xenogeneic immunization in mice using HER2 DNA delivered by an adenoviral vector.
2005,
Pubmed
Greiner,
Receptor for hyaluronan acid-mediated motility (RHAMM) is a new immunogenic leukemia-associated antigen in acute and chronic myeloid leukemia.
2002,
Pubmed
Groen,
XRHAMM functions in ran-dependent microtubule nucleation and pole formation during anastral spindle assembly.
2004,
Pubmed
,
Xenbase
Gurunathan,
DNA vaccines: immunology, application, and optimization*.
2000,
Pubmed
Hall,
Overexpression of the hyaluronan receptor RHAMM is transforming and is also required for H-ras transformation.
1995,
Pubmed
Hardwick,
Molecular cloning of a novel hyaluronan receptor that mediates tumor cell motility.
1992,
Pubmed
He,
Inhibition of tumor growth with a vaccine based on xenogeneic homologous fibroblast growth factor receptor-1 in mice.
2003,
Pubmed
,
Xenbase
Hofmann,
Identification of IHABP, a 95 kDa intracellular hyaluronate binding protein.
1998,
Pubmed
Jäger,
Identification of a tissue-specific putative transcription factor in breast tissue by serological screening of a breast cancer library.
2001,
Pubmed
Krackhardt,
Identification of tumor-associated antigens in chronic lymphocytic leukemia by SEREX.
2002,
Pubmed
Line,
Characterisation of tumour-associated antigens in colon cancer.
2002,
Pubmed
Liu,
Immunotherapy of tumors with vaccine based on quail homologous vascular endothelial growth factor receptor-2.
2003,
Pubmed
Lokeshwar,
Differences in hyaluronic acid-mediated functions and signaling in arterial, microvessel, and vein-derived human endothelial cells.
2000,
Pubmed
Marin,
Endothelial cell culture: protocol to obtain and cultivate human umbilical endothelial cells.
2001,
Pubmed
Marincola,
Escape of human solid tumors from T-cell recognition: molecular mechanisms and functional significance.
2000,
Pubmed
Murray,
Embryo implantation and tumor metastasis: common pathways of invasion and angiogenesis.
1999,
Pubmed
Neal,
Hydrodynamic limb vein delivery of a xenogeneic DNA cancer vaccine effectively induces antitumor immunity.
2007,
Pubmed
Palomba,
CD8+ T-cell-dependent immunity following xenogeneic DNA immunization against CD20 in a tumor challenge model of B-cell lymphoma.
2005,
Pubmed
Pupa,
Inhibition of mammary carcinoma development in HER-2/neu transgenic mice through induction of autoimmunity by xenogeneic DNA vaccination.
2005,
Pubmed
Quenby,
Oncogene and tumour suppressor gene products during trophoblast differentiation in the first trimester.
1998,
Pubmed
Rafii,
Vaccination against tumor neovascularization: Promise and reality.
2002,
Pubmed
Rein,
Expression of the hyaluronan receptor RHAMM in endometrial carcinomas suggests a role in tumour progression and metastasis.
2003,
Pubmed
Roberts,
Antiangiogenic and antitumor activity of a selective PDGFR tyrosine kinase inhibitor, CP-673,451.
2005,
Pubmed
Rosenberg,
Progress in human tumour immunology and immunotherapy.
2001,
Pubmed
Sahin,
Human neoplasms elicit multiple specific immune responses in the autologous host.
1995,
Pubmed
Savani,
Differential involvement of the hyaluronan (HA) receptors CD44 and receptor for HA-mediated motility in endothelial cell function and angiogenesis.
2001,
Pubmed
Sparmann,
Ras-induced interleukin-8 expression plays a critical role in tumor growth and angiogenesis.
2004,
Pubmed
Srinivasan,
Tumor antigens for cancer immunotherapy: therapeutic potential of xenogeneic DNA vaccines.
2004,
Pubmed
Tetens,
Expression of proto-oncogenes in bovine preimplantation blastocysts.
2000,
Pubmed
Turley,
Hyaluronan and cell locomotion.
1992,
Pubmed
Wang,
RNA interference against Biot2, a novel mouse testis-specific gene, inhibits the growth of tumor cells.
2009,
Pubmed
Wei,
Immunogene therapy of tumors with vaccine based on Xenopus homologous vascular endothelial growth factor as a model antigen.
2001,
Pubmed
,
Xenbase
Wei,
Immunotherapy of tumors with xenogeneic endothelial cells as a vaccine.
2000,
Pubmed
Yang,
Characterization of a novel rat gene RTAP2a, screened by cross-reactive SEREX, restrictedly expressed in testis.
2009,
Pubmed
